NumFin

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

符号: 002603.SZ

SHZ

19.58

CNY

今天的市场价格

  • 12.0881

    市盈率

  • 1.2606

    PEG比率

  • 32.71B

    MRK市值

  • 0.03%

    DIV收益率

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603-SZ) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ). 的默认数据。公司收入显示 4426.104 M 的平均值，即 0.201 % 增长率。整个期间的平均毛利润为 2862.493 M，即 0.203 %. 平均毛利率为 0.649 %. 公司去年的净收入增长率为 0.757 %，等于 0.291 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Shijiazhuang Yiling Pharmaceutical Co., Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.266. 在流动资产领域，002603.SZ 的报告货币为7254.187. 这些资产中的很大一部分，即 2422.66 是现金和短期投资。与去年的数据相比，该部分的变化率为1.306%. 公司的长期投资虽然不是其重点，但以报告货币计算的830.52（如果有的话）为830.52。这表明与上一报告期相比，-1630.261% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 215.123. 这一数字表明，-0.151% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 10932.217. 这方面的年同比变化率为 0.205%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为2699.567，存货估值为 2021.82，商誉估值为 0（如有. 无形资产总额（如果有）按 827.96 估值.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

balance-sheet.row.cash-and-short-term-investments

8322.472422.71050.51554
1026.1
1129
802.7
534.1
430.6
401.5
709.6
1499.1
1962.5
403.1
210.8
126.1

balance-sheet.row.short-term-investments

2554.79518.455.3217
292.7
351.8
-26.4
-304.5
-28.7
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

11259.242699.62593.12102.4
2765.8
2207.2
1379.2
938.8
784.9
589.1
882.9
739.8
924
280.8
765.7
329.9

balance-sheet.row.inventory

9782.922021.81672.71580.3
1221.8
1175.7
1075.6
921.7
1037.9
833.7
618.4
455.7
326.7
210.1
144.4
67.8

balance-sheet.row.other-current-assets

631.46110.1285.8222.7
54.5
386.3
889.1
131.6
69
418.1
484.4
0
-30.6
-1.2
-192.1
-78.2

balance-sheet.row.total-current-assets

29996.097254.25602.15459.4
5068.2
4898.3
4146.6
2526.2
2322.3
2242.4
2695.3
2694.5
3182.6
892.8
928.8
445.7

balance-sheet.row.property-plant-equipment-net

26574.196221.85745.54299.1
3051.2
2852.6
2997.6
2727.2
2729
1963.1
1526.8
1105.3
764.4
622.9
485.8
350.9

balance-sheet.row.goodwill

228.47000
0
0
11.9
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

3445.29828897.9736.6
754.4
562
537.8
514.6
466.6
378.5
354
340.7
263.8
246.8
90.6
32.1

balance-sheet.row.goodwill-and-intangible-assets

3673.77828897.9736.6
754.4
562
549.7
514.6
466.6
378.5
354
340.7
263.8
246.8
90.6
32.1

balance-sheet.row.long-term-investments

4655.45830.5-54.3-216
-291.7
-301.3
117
373.5
31.3
44.1
0
0
0
0
0
0

balance-sheet.row.tax-assets

820.62279.9117137.8
68.1
59.2
35.4
29.8
33.9
27.9
15.8
20.8
10.5
7.3
3.4
2.4

balance-sheet.row.other-non-current-assets

4451.29921.8596.61075.3
419.3
486.4
41.1
79.2
123.9
431.8
66.1
4.4
4.1
1.3
0.8
0.9

balance-sheet.row.total-non-current-assets

40175.329081.97302.76032.9
4001.2
3659
3740.8
3724.2
3384.6
2845.5
1962.7
1471.2
1042.8
878.3
580.6
386.2

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

70171.4216336.112904.811492.3
9069.4
8557.2
7887.4
6250.5
5707
5087.9
4658
4165.7
4225.4
1771.1
1509.4
831.9

balance-sheet.row.account-payables

10015.92060.81621.21188.4
506.8
389
353
307.7
373.2
247.1
141.9
69.8
72.8
86.5
115.9
46.4

balance-sheet.row.short-term-debt

3422.6656.3513.9270.2
50.1
0
0
100
50
0
0
0
201
160
0
30

balance-sheet.row.tax-payables

1098.62474123.2133.9
99.5
94.9
89.8
106.1
40.2
24.1
-1.3
1.7
37.4
143
110.8
2.8

balance-sheet.row.long-term-debt-total

1455.8215.151310.5
0
0
0
0
0
0
0
47
47
46
0
0

Deferred Revenue Non Current

1400.88335357.8328.1
310.4
228.9
168.3
177.2
172.1
166.5
159.8
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

263.2---
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

1781.831027.3216.328.3
46.2
375.6
254.2
99.3
60.8
120.2
105.1
60.4
28.8
45.3
524.9
19.9

balance-sheet.row.total-non-current-liabilities

3119.87555.7872.2330.1
310.4
228.9
168.3
177.2
172.1
166.5
152.7
190.5
149.8
146
78.1
59.5

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

54.951512.510.5
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

23563.795405.83832.72569
1116.9
993.6
775.6
917.8
879.6
533.8
399.7
320.8
523.8
680.1
718.9
347.9

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

6682.821670.71670.71203.7
1203.7
1206.3
1204.6
1128.8
1127.6
563.4
563.9
552.5
425
360
79.9
79.9

balance-sheet.row.retained-earnings

26853.235989.24306.24324.4
3483.1
3071.7
2650.1
2290
1902.1
1562.9
1293.1
1117.9
990.9
571.9
564.6
267.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

8524.94989808.9640.9
507.3
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

4566.632283.32283.32750.3
2750.3
3283.1
3255.5
1903
1785.9
2427.8
2401.4
2174.6
2285.8
159.1
143.3
134.2

balance-sheet.row.total-stockholders-equity

46627.6210932.29069.18919.3
7944.4
7561.1
7110.2
5321.8
4815.6
4554.1
4258.3
3845
3701.6
1091
787.7
481.5

balance-sheet.row.total-liabilities-and-stockholders-equity

70171.4216336.112904.811492.3
9069.4
8557.2
7887.4
6250.5
5707
5087.9
4658
4165.7
4225.4
1771.1
1509.4
831.9

balance-sheet.row.minority-interest

-19.99-1.934.1
8.1
2.5
1.6
10.8
11.8
0
0
0
0
0
2.9
2.5

balance-sheet.row.total-equity

46607.6310930.39072.28923.4
7952.5
7563.7
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

70171.42---
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

7210.241348.911
1
50.5
90.6
69
2.5
44.1
0
0
0
0
0
0

balance-sheet.row.total-debt

4878.39871.41026.9270.2
50.1
0
0
100
50
0
0
47
248
206
0
30

balance-sheet.row.net-debt

-889.29-1032.831.6-1066.8
-683.4
-777.3
-802.7
-434.1
-380.6
-401.5
-709.6
-1452.1
-1714.5
-197.1
-210.8
-96.1

现金流量表

在 Shijiazhuang Yiling Pharmaceutical Co., Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 23.599 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 1886.22. 公司的投资活动产生了现金使用净额，按报告货币计算达到-1994800827.610. 与上一年相比， 2.936 发生了变化. 在同一时期，公司记录了 451.47, 0 和 -2200.01，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-282.7 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 1845.71，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

cash-flows.row.net-income

2706.162356.81341.61214.9
603
593
536.8
535.9
426.8
354.5
244.3
185.8
454.1
315
297.5
122.3

cash-flows.row.depreciation-and-amortization

121.87451.5362.9268.2
259.7
253.2
244.7
216.8
144.6
85.5
64
61.2
58.7
49
34.1
29.7

cash-flows.row.deferred-income-tax

0-158.720.1-67.7
-8.9
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0158.7-20.167.7
8.9
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-1179.67547.8-1309.724.8
-856.5
-760.4
-659.7
-138
-443.1
-341.5
-264.6
-189.9
-941
-61.1
-20.6
53.8

cash-flows.row.account-receivables

-831.66-831.7-1280.3-668.7
-800.4
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-348.01-348-104.7-364.9
-40.8
-105.4
-148
116.1
-204.1
-212.6
-162.7
-128.9
-116.6
-65.7
-76.6
7.1

cash-flows.row.account-payables

22.821886.255.11126.1
-6.4
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-22.82-158.720.1-67.7
-8.9
-655
-511.7
-254.2
-239
-128.8
-101.9
-61
-824.4
4.6
56.1
46.6

cash-flows.row.other-non-cash-items

245.91131.6133.978.3
62.7
-13.4
-7.1
16.9
3.6
7.3
11.6
13.1
19.7
-3.2
7.2
4.4

cash-flows.row.net-cash-provided-by-operating-activities

1894.27000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-246.9-214-673.6-1144.8
-454.4
-187.2
-180.3
-373
-478.4
-450.2
-409.8
-296.9
-177.9
-285
-210.6
-128.3

cash-flows.row.acquisitions-net

-628.540.42.41145.1
7.1
0
-1.7
373.2
478.5
450.6
409.9
0
0
-25.6
0
0

cash-flows.row.purchases-of-investments

-5902.36-3461.9-451-2853.3
-2114.8
-1374.8
-1756.5
-247.1
-89.3
-1500.8
-1210
0
0
287.8
0
0

cash-flows.row.sales-maturities-of-investments

4047.541680.7616.62957.6
2599
1599.7
985
115.1
462.6
1596.9
733.9
0
0
0.6
0
0

cash-flows.row.other-investing-activites

0.360-1.2-1144.8
0.2
8.6
1.1
-373
-478.4
-450.2
-409.8
0.2
0
-285
0
0.2

cash-flows.row.net-cash-used-for-investing-activites

-2729.91-1994.8-506.8-1040.2
37.1
46.4
-952.5
-504.9
-105
-353.7
-885.9
-296.7
-177.9
-307.2
-210.6
-128.1

cash-flows.row.debt-repayment

-1250-2200-1469.9-270
-50
0
-100
-50
-60
0
-47
-251
-261
0
-110
-30

cash-flows.row.common-stock-issued

0000
50
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
-100
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-413.64-282.7-1220.1-244.1
-119.8
-120.6
-103.1
-86.9
-58.4
-55.2
-56.1
-35.9
-56.1
-4.8
-1.9
-83.7

cash-flows.row.other-financing-activites

1321.671845.72387.9490.8
50.2
-23.2
1295.8
113.5
120.8
-5.1
144.2
50
2462.8
204.5
89
94.5

cash-flows.row.net-cash-used-provided-by-financing-activities

-341.96-637-302.1-23.3
-169.6
-143.9
1092.7
-23.3
2.4
-60.3
41.2
-236.9
2145.7
199.7
-22.9
-19.2

cash-flows.row.effect-of-forex-changes-on-cash

0.281.2-0.5-2
-0.6
0
-0.2
0.1
-0.2
0.1
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-663.1857.2-280.7520.8
-64.2
-25.1
254.6
103.5
29.1
-308.1
-789.4
-463.4
1559.4
192.3
84.7
62.9

cash-flows.row.cash-at-end-of-period

5395.811810.7953.51234.2
713.4
777.6
802.7
534.1
430.6
401.5
709.6
1499.1
1962.5
403.1
210.8
126.1

cash-flows.row.cash-at-beginning-of-period

6058.9953.51234.2713.4
777.6
802.7
548.1
430.6
401.5
709.6
1499.1
1962.5
403.1
210.8
126.1
63.3

cash-flows.row.operating-cash-flow

1894.273487.7528.71586.2
68.9
72.4
114.7
631.6
131.9
105.9
55.3
70.1
-408.5
299.7
318.2
210.2

cash-flows.row.capital-expenditure

-246.9-214-673.6-1144.8
-454.4
-187.2
-180.3
-373
-478.4
-450.2
-409.8
-296.9
-177.9
-285
-210.6
-128.3

cash-flows.row.free-cash-flow

1647.373273.8-144.9441.4
-385.5
-114.9
-65.7
258.6
-346.6
-344.3
-354.5
-226.8
-586.4
14.7
107.6
81.9

利润表行

Shijiazhuang Yiling Pharmaceutical Co., Ltd. 的收入与上期相比变化了 0.239%。据报告, 002603.SZ 的毛利润为 7992.27。该公司的营业费用为 5025.83，与上年相比变化了 5.614%. 折旧和摊销费用为 451.47，与上一会计期间相比变化了 0.217%. 营业费用报告为 5025.83，显示5.614% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长0.803%. 营业收入为 2829.56，与上年相比变化了0.803%. 净利润的变化率为 0.757%。去年的净收入为2361.8.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

income-statement-row.row.total-revenue

13161.6612532.810116.88782.5
5825.3
4814.6
4081.3
3820.2
3184.8
2921.2
2490.2
1648.7
1953.2
1649.3
1632.3
938.6

income-statement-row.row.cost-of-revenue

4867.044540.636813118.4
2106.2
1630.8
1303.9
1287.7
1164.4
1077.7
830.5
524
617.7
554.7
636.8
379.7

income-statement-row.row.gross-profit

8294.627992.36435.85664.1
3719.1
3183.7
2777.4
2532.5
2020.3
1843.5
1659.7
1124.6
1335.5
1094.6
995.5
558.8

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

1074.04---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

235.76---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

3177.48---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

505.39576.9366.6323
301.6
-17.9
-10.9
14.3
0.7
3.9
16.1
28.1
42.9
23.8
15.7
-6

income-statement-row.row.operating-expenses

4982.245025.84758.74179.2
3034
2499.5
2144.1
1904
1541.9
1462.3
1424.8
975.5
846.7
747.5
650.5
404.6

income-statement-row.row.cost-and-expenses

9849.299566.48439.77297.6
5140.2
4130.3
3448.1
3191.7
2706.3
2540
2255.3
1499.5
1464.4
1302.2
1287.4
784.3

income-statement-row.row.interest-income

14.3412.920.47
2.3
17.7
4.7
-1.9
2.8
8.6
34.3
50.6
26.6
1.8
1.1
0.5

income-statement-row.row.interest-expense

36.7533.8343.8
0.1
0
1.5
3.2
2.8
2.8
0
6.9
20.2
7.9
2
1.7

income-statement-row.row.selling-and-marketing-expenses

3177.48---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-20.99-48.9-15.4-15.6
-2.3
16.8
5.1
9.2
20.9
29.4
54.5
67.1
43.7
21.6
9.3
-10

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

505.39576.9366.6323
301.6
-17.9
-10.9
14.3
0.7
3.9
16.1
28.1
42.9
23.8
15.7
-6

income-statement-row.row.total-operating-expenses

-20.99-48.9-15.4-15.6
-2.3
16.8
5.1
9.2
20.9
29.4
54.5
67.1
43.7
21.6
9.3
-10

income-statement-row.row.interest-expense

36.7533.8343.8
0.1
0
1.5
3.2
2.8
2.8
0
6.9
20.2
7.9
2
1.7

income-statement-row.row.depreciation-and-amortization

100.71546.1448.6329.5
261.4
253.2
244.7
216.8
144.6
85.5
64
61.2
58.7
49
34.1
29.7

income-statement-row.row.ebitda-caps

3303.32---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

3202.612829.61569.11438
710.2
719
649.2
623.7
499
410
273.2
188.2
489.6
345.7
339.6
150.4

income-statement-row.row.income-before-tax

3181.622780.61553.71422.5
707.9
701
638.3
637.7
499.4
410.6
289.3
216.2
532.5
368.8
354.3
144.2

income-statement-row.row.income-tax-expense

482.98423.8212.1207.5
104.8
108
101.6
101.8
72.6
56.1
45
30.4
78.4
53.7
56.8
22

income-statement-row.row.net-income

2706.162361.81343.91218.7
606.5
599.2
540.7
542
430.5
354.5
244.3
185.8
454.1
315.6
297.2
122.1
类似股票
您可能还对以下内容感兴趣：
MRVI
Maravai LifeSciences Holdings, Inc..
7.7 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.0361 USD
NASDAQ
T5O.DE
CytoTools AG.
0.488 EUR
XETRA
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ
SPHRF
Starpharma Holdings Limited.
0.0991 USD
PNK
ARQT
Arcutis Biotherapeutics, Inc..
8.47 USD
NASDAQ

常见问题

什么是 Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) 总资产是多少？

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) 总资产为 16336112689.000.

什么是企业年收入？

年收入为 4639721722.000.

企业利润率是多少？

公司利润率为 0.630.

什么是公司自由现金流？

自由现金流为 0.986.

什么是企业净利润率？

净利润率为 0.206.

企业总收入是多少？

总收入为 0.243.

什么是 Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 2361804714.000.

公司总债务是多少？

债务总额为 871449540.000.

营业费用是多少？

运营支出为 5025828583.000.

公司现金是多少？

企业现金为 1072618858.000.